Rifaximin ameliorates intestinal inflammation in cirrhotic patients with hepatic encephalopathy. Issue 7 (23rd June 2021)

Record Type:: Journal Article
Title:: Rifaximin ameliorates intestinal inflammation in cirrhotic patients with hepatic encephalopathy. Issue 7 (23rd June 2021)
Main Title:: Rifaximin ameliorates intestinal inflammation in cirrhotic patients with hepatic encephalopathy
Authors:: Tamai, Yasuyuki
Iwasa, Motoh
Eguchi, Akiko
Shigefuku, Ryuta
Kamada, Yoshihiro
Miyoshi, Eiji
Takei, Yoshiyuki
Abstract:: Abstract : Rifaximin (RFX) treatment can attenuate not only hyperammonemia but also Enterococcus faecalis translocation and 10‐7G values, suggesting that RFX treatment may improve intestinal inflammation and result in better overall survival.
Is Part Of:: JGH open. Volume 5:Issue 7(2021)
Journal:: JGH open
Issue:: Volume 5:Issue 7(2021)
Issue Display:: Volume 5, Issue 7 (2021)
Year:: 2021
Volume:: 5
Issue:: 7
Issue Sort Value:: 2021-0005-0007-0000
Page Start:: 827
Page End:: 830
Publication Date:: 2021-06-23
Subjects:: hepatic encephalopathy -- intestinal inflammation -- liver cirrhosis -- rifaximin
Journal URLs:: http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1002/jgh3.12596 ↗
Languages:: English
ISSNs:: 2397-9070
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 17864.xml